AVANTI 340B Trademark

Trademark Overview

On Wednesday, May 17, 2023, a trademark application was filed for AVANTI 340B with the United States Patent and Trademark Office. The USPTO has given the AVANTI 340B trademark a serial number of 98001359. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 18, 2024. This trademark is owned by RxX Advisory Services, LLC. The AVANTI 340B trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business consulting services in the field of compliance with federal regulations in regard to drug pricing
avanti 340b

General Information

Serial Number98001359
Word MarkAVANTI 340B
Filing DateWednesday, May 17, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, June 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements

Pseudo MarkAVANTI THREE FOUR ZERO B; AVANTI THREE HUNDRED FORTY B
Goods and ServicesBusiness consulting services in the field of compliance with federal regulations in regard to drug pricing
Translation of Words in MarkThe English translation of AVANTI in the mark is "come in" and "move forward".
NOT AVAILABLE"340B"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, June 20, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRxX Advisory Services, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressPalo Alto, CA 94304
Party NameRxX Advisory Services, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPalo Alto, CA 94304

Trademark Events

Event DateEvent Description
Saturday, May 20, 2023NEW APPLICATION ENTERED
Tuesday, June 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 13, 2023ASSIGNED TO EXAMINER
Thursday, December 14, 2023NON-FINAL ACTION WRITTEN
Thursday, December 14, 2023NON-FINAL ACTION E-MAILED
Thursday, December 14, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 14, 2023REMOVED FROM TEAS PLUS
Friday, December 29, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 29, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, December 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 2, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 16, 2024WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, January 18, 2024PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, January 18, 2024NON-FINAL ACTION WRITTEN
Thursday, January 18, 2024NON-FINAL ACTION E-MAILED
Thursday, January 18, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 19, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 21, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

avanti regulations regard drug pricing federal compliance consulting services field business